Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).
暂无分享，去创建一个
A. Gemma | S. Morita | Kunihiko Kobayashi | T. Harada | S. Oizumi | K. Yoshimori | M. Maemondo | T. Nukiwa | I. Kinoshita | S. Sugawara | A. Inoue | M. Harada | H. Yoshizawa | Y. Fujita | S. Okinaga | H. Hirano | Y. Saijo | K. Hagiwara | H. Isobe | K. Kobayashi | Satoshi Morita | K. Kobayashi